• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择用于核心结局集的结局测量工具,以改善初级保健中老年人群中适当的多药治疗:一项德尔菲共识研究。

Selection of outcome measurement instruments for a core outcome set for trials aimed at improving appropriate polypharmacy in older people in primary care: a Delphi consensus study.

机构信息

Primary Care Research Group, School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK.

出版信息

Int J Clin Pharm. 2024 Dec;46(6):1391-1399. doi: 10.1007/s11096-024-01780-4. Epub 2024 Jul 23.

DOI:10.1007/s11096-024-01780-4
PMID:39042350
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11576772/
Abstract

BACKGROUND

Despite developing a polypharmacy core outcome set (COS) in primary care, it is not clear how these outcomes should be measured.

AIM

To select outcome measurement instruments (OMIs) for a COS targeting appropriate polypharmacy in older patients in primary care.

METHOD

Following the Consensus-based Standards for the selection of health Measurement Instruments (COSMIN) guideline, OMIs were identified from a Cochrane review focusing on appropriate polypharmacy. The quality of OMIs was assessed using a published checklist. Subsequently, two rounds of Delphi questionnaires were conducted via the SoGoSurvey platform, engaging stakeholders (researchers, clinicians and journal editors specialising in geriatric primary care) to achieve consensus on OMIs using a scale encompassing "agree", "disagree", or "unsure". Consensus was achieved if 70% or more participants chose "agree" and 15% or fewer chose "disagree."

RESULTS

The quality of 20 OMIs identified from the Cochrane review was evaluated. Seven OMIs were selected based on meeting the COSMIN guideline's minimum requirements. Out of 188 potential participants, 57 (30.3%) consented to participate. Rounds 1 and 2 of Delphi exercises were completed by 50 respondents, achieving agreement on three OMIs: 'number of serious adverse drug reactions (ADRs)' (98%), 'number of deaths' (76%), and 'number of patients who fell' (70%) for measuring 'serious ADRs,' 'mortality,' and 'falls,' respectively. No agreement was reached for 'medication appropriateness,' 'medication side-effects,' 'quality of life,' and 'medication regimen complexity.'

CONCLUSION

OMIs were selected for a limited number of outcomes in the polypharmacy COS. Future research should identify suitable OMIs for the remaining four outcomes.

摘要

背景

尽管在初级保健中制定了一个多药治疗核心结局集(COS),但仍不清楚应该如何衡量这些结局。

目的

为初级保健中老年患者的适当多药治疗选择一个 COS 的结局测量工具(OMI)。

方法

根据共识基础的健康测量仪器选择标准(COSMIN)指南,从一项专门针对适当多药治疗的 Cochrane 综述中确定了 OMI。使用已发表的清单评估 OMI 的质量。随后,通过 SoGoSurvey 平台进行了两轮 Delphi 问卷调查,让利益攸关方(研究人员、临床医生和专门从事老年初级保健的期刊编辑)参与,使用涵盖“同意”、“不同意”或“不确定”的量表就 OMI 达成共识。如果 70%或更多的参与者选择“同意”,而 15%或更少的参与者选择“不同意”,则达成共识。

结果

对从 Cochrane 综述中确定的 20 个 OMI 的质量进行了评估。根据符合 COSMIN 指南最低要求,选择了 7 个 OMI。在 188 名潜在参与者中,有 57 名(30.3%)同意参与。在第一轮和第二轮 Delphi 练习中,有 50 名受访者完成了练习,就三个 OMI 达成了一致:“严重药物不良反应(ADR)的数量”(98%)、“死亡人数”(76%)和“跌倒人数”(70%),分别用于衡量“严重 ADR”、“死亡率”和“跌倒”。对于“药物适宜性”、“药物副作用”、“生活质量”和“药物治疗方案的复杂性”,没有达成一致意见。

结论

为多药治疗 COS 中的一些结局选择了 OMI。未来的研究应该为其余四个结局确定合适的 OMI。

相似文献

1
Selection of outcome measurement instruments for a core outcome set for trials aimed at improving appropriate polypharmacy in older people in primary care: a Delphi consensus study.选择用于核心结局集的结局测量工具,以改善初级保健中老年人群中适当的多药治疗:一项德尔菲共识研究。
Int J Clin Pharm. 2024 Dec;46(6):1391-1399. doi: 10.1007/s11096-024-01780-4. Epub 2024 Jul 23.
2
Measuring communication as a core outcome in aphasia trials: Results of the ROMA-2 international core outcome set development meeting.测量失语症试验中的沟通情况作为核心结局指标:ROMAA-2 国际核心结局集开发会议的结果。
Int J Lang Commun Disord. 2023 Jul-Aug;58(4):1017-1028. doi: 10.1111/1460-6984.12840. Epub 2022 Dec 30.
3
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.系统评价报告结局测量工具(OMIs)的指南:PRISMA-COSMIN 对 OMIs 的 2024 年修订版。
Health Qual Life Outcomes. 2024 Jul 9;22(1):48. doi: 10.1186/s12955-024-02256-9.
4
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.报告结局测量工具(OMIs)系统评价的指南:2024 年 OMIs 的 PRISMA-COSMIN。
J Patient Rep Outcomes. 2024 Jul 9;8(1):64. doi: 10.1186/s41687-024-00727-7.
5
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.报告结局测量工具(OMIs)系统评价的指南:PRISMA-COSMIN 2024 年 OMIs 版。
J Clin Epidemiol. 2024 Sep;173:111422. doi: 10.1016/j.jclinepi.2024.111422. Epub 2024 Jul 9.
6
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.报告结局测量工具(OMIs)系统评价的指南:PRISMA-COSMIN 2024 版。
Qual Life Res. 2024 Aug;33(8):2029-2046. doi: 10.1007/s11136-024-03634-y. Epub 2024 Jul 9.
7
Core Outcome Set for Trials Aimed at Improving the Appropriateness of Polypharmacy in Older People in Primary Care.旨在提高初级保健中老年人群药物治疗适宜性的试验的核心结局集。
J Am Geriatr Soc. 2018 Jul;66(6):1206-1212. doi: 10.1111/jgs.15245. Epub 2018 Feb 20.
8
Development of a core outcome set for clinical trials aimed at improving antimicrobial stewardship in care homes.制定旨在改善养老院中抗菌药物管理的临床试验核心结局集。
Antimicrob Resist Infect Control. 2021 Mar 9;10(1):52. doi: 10.1186/s13756-021-00925-8.
9
How to select outcome measurement instruments for outcomes included in a "Core Outcome Set" - a practical guideline.如何为“核心结局集”中包含的结局选择结局测量工具——实用指南
Trials. 2016 Sep 13;17(1):449. doi: 10.1186/s13063-016-1555-2.
10
International development and implementation of a core measurement set for research and audit studies in implant-based breast reconstruction: a study protocol.国际研究和审计研究中基于植入物的乳房重建核心测量集的制定和实施:研究方案。
BMJ Open. 2020 Jan 20;10(1):e035505. doi: 10.1136/bmjopen-2019-035505.

本文引用的文献

1
Defining quality indicators, pharmaceutical care bundles and outcomes of clinical pharmacy service delivery using a Delphi consensus approach.采用德尔菲共识方法定义质量指标、药学护理包和临床药学服务提供的结果。
Int J Clin Pharm. 2024 Apr;46(2):451-462. doi: 10.1007/s11096-023-01681-y. Epub 2024 Jan 19.
2
Interventions to improve the appropriate use of polypharmacy for older people.干预措施以改善老年人的药物合用(polypharmacy)的合理使用。
Cochrane Database Syst Rev. 2023 Oct 11;10(10):CD008165. doi: 10.1002/14651858.CD008165.pub5.
3
Medication-related quality of life (MRQoL) in ambulatory older adults with multi-morbidity and polypharmacy.
患有多种慢性病和多种药物治疗的门诊老年患者的药物相关生活质量 (MRQoL)。
Eur Geriatr Med. 2022 Jun;13(3):579-583. doi: 10.1007/s41999-021-00573-6. Epub 2021 Oct 21.
4
Development of a core outcome set for clinical trials aimed at improving antimicrobial stewardship in care homes.制定旨在改善养老院中抗菌药物管理的临床试验核心结局集。
Antimicrob Resist Infect Control. 2021 Mar 9;10(1):52. doi: 10.1186/s13756-021-00925-8.
5
Interprofessional Medication Assessment has Effects on the Quality of Medication Among Home Care Patients: Randomized Controlled Intervention Study.跨专业药物评估对居家护理患者的用药质量有影响:随机对照干预研究。
J Am Med Dir Assoc. 2021 Jan;22(1):74-81. doi: 10.1016/j.jamda.2020.07.007. Epub 2020 Sep 3.
6
Methods used in the selection of instruments for outcomes included in core outcome sets have improved since the publication of the COSMIN/COMET guideline.用于选择核心结局集包含结局指标的工具的方法,自 COSMIN/COMET 指南发布以来已经得到了改进。
J Clin Epidemiol. 2020 Sep;125:64-75. doi: 10.1016/j.jclinepi.2020.05.021. Epub 2020 May 26.
7
Medication-related quality of life among Ethiopian elderly patients with polypharmacy: A cross-sectional study in an Ethiopia university hospital.多药治疗的埃塞俄比亚老年患者的药物相关生活质量:埃塞俄比亚大学医院的一项横断面研究。
PLoS One. 2019 Mar 28;14(3):e0214191. doi: 10.1371/journal.pone.0214191. eCollection 2019.
8
Core Outcome Set for Trials Aimed at Improving the Appropriateness of Polypharmacy in Older People in Primary Care.旨在提高初级保健中老年人群药物治疗适宜性的试验的核心结局集。
J Am Geriatr Soc. 2018 Jul;66(6):1206-1212. doi: 10.1111/jgs.15245. Epub 2018 Feb 20.
9
Developing a Core Outcome Set for Trials to Improve Medication Use: Guidelines or Guidance?制定改善药物使用试验的核心结局集:指南还是指导意见?
J Am Geriatr Soc. 2018 Jul;66(6):1058-1059. doi: 10.1111/jgs.15269. Epub 2018 Feb 20.
10
Core outcome measurement instruments for clinical trials in nonspecific low back pain.非特异性下腰痛临床试验的核心结局测量工具。
Pain. 2018 Mar;159(3):481-495. doi: 10.1097/j.pain.0000000000001117.